News

We're wrapping up the blog for the day. Here's everything you need to know about what happened. Thanks for joining us, we will be bringing you updates again tomorrow. Opposition leader Peter ...
The Government is to host the first international summit in the UK on how to tackle people-smuggling gangs. Ministers and enforcement staff from 40 countries will meet in London on Monday and Tuesday ...
It is a bittersweet, yet exciting, time for the ICO’s team. We concluded our service under outgoing Commissioner Gutierrez and now welcome the leadership of new Information Commissioner ...
H.C. Wainwright keeps a Buy rating on Milestone Pharmaceuticals (MIST) after the company announced receipt of a complete response letter from the FDA regarding its new drug application for its ...
Following two recent South Orange-Maplewood School District town halls — one on transportation and one on budget — where some community members questioned the continuation of the district’s ...
Academy Faculty Member, The Queen Elizabeth II Academy, Chatham House; Claire Tow Professor of Political Science, Barnard College, Columbia University The ‘liberal international order’ that has been ...
NLIHC’s annual housing policy forum is an opportunity to engage with and learn from thought leaders, policy experts, researchers, tenant advocates, affordable housing practitioners, and members of ...
Explore how ICO-era dynamics apply to crypto agents, from the narrative-driven early phase to a mature state where value is created through long-term data, revenue and innovation. The rise of AI ...
Former APC North-West Vice Chairman, Salihu Lukman, has revealed that discussions on forming a unified opposition party to challenge the ruling All Progressives Congress (APC) in the 2027 ...
LONDON – French President Emmanuel Macron said leaders of the coalition backing Ukraine would meet again next week, hoping to finalise plans to secure a potential truce in the war with Russia.
Goldman Sachs downgraded contract research organizations Icon Public Limited (NASDAQ:ICLR) and Charles River Laboratories (NYSE:CRL) to Neutral from Buy on Friday, citing a challenging near-term ...
Charles River Labs (CRL – Research Report) received a Hold rating and price target from Goldman Sachs analyst Matthew Sykes today. The company’s shares closed yesterday at $165.35. Easily ...